Medicare Enrolled
Dr. Alexis Shaefer, M.D.
Neurology · Augusta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shaefer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shaefer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shaefer
Dr. Alexis Shaefer is a neurology specialist in Augusta, GA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Shaefer performed 17,872 Medicare services across 1,423 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shaefer received a total of $249,455 from 74 pharmaceutical and/or device companies across 1439 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shaefer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 5% volume in GA
$249,455 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,872
Medicare services
Top 5% in GA for neurology
1,423
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,191 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
16,000 | $5 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
918 | $84 | $200 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
164 | $70 | $284 |
| New patient office visit, complex (60-74 min) | 144 | $141 | $400 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
125 | $116 | $280 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
81 | $135 | $640 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
81 | $59 | $140 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
80 | $99 | $320 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
59 | $115 | $700 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
59 | $149 | $1,400 |
| Chemical nerve block injection, 5+ arm/leg muscles Injection of a chemical agent to paralyze five or more muscles in the first extremity treated. |
36 | $110 | $510 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 33 | $43 | $250 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
29 | $128 | $1,120 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
28 | $257 | $750 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
24 | $193 | $1,960 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
11 | $158 | $1,680 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$249,455
Total received (2018-2024)
Avg $35,636/year across 7 years
Top 3% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
1,439
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$227,313 (91.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,200 (7.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,942 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$47,811
2023
$19,829
2022
$67,104
2021
$63,276
2020
$46,365
2019
$2,842
2018
$2,228
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$37,698
ABBVIE INC.
$6,760
ARGENX US, INC.
$316
PFIZER INC.
$302
Neurocrine Biosciences, Inc.
$255
MDD US Operations, LLC
$211
Teva Pharmaceuticals USA, Inc.
$210
Novartis Pharmaceuticals Corporation
$171
UCB, Inc.
$144
Eisai Inc.
$143
Lilly USA, LLC
$138
SK Life Science, Inc.
$134
Lundbeck LLC
$127
BANNER LIFE SCIENCES, LLC
$122
Neurelis, Inc.
$119
Otsuka America Pharmaceutical, Inc.
$108
SCILEX PHARMACEUTICALS INC.
$92
AstraZeneca Pharmaceuticals LP
$90
EMD Serono, Inc.
$87
Genentech USA, Inc.
$83
Alexion Pharmaceuticals, Inc.
$71
Biogen, Inc.
$61
Kyowa Kirin, Inc.
$47
Grifols USA, LLC
$44
Mallinckrodt Hospital Products Inc.
$43
Acorda Therapeutics, Inc
$40
LivaNova USA, Inc.
$39
Janssen Pharmaceuticals, Inc
$27
Merz Pharmaceuticals, LLC
$27
CATALYST PHARMACEUTICALS, INC.
$26
Vanda Pharmaceuticals Inc.
$23
TG Therapeutics, Inc.
$19
Kedrion Biopharma, Inc.
$19
Boston Scientific Corporation
$16
Top 3 companies account for 93.6% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$69,431
ABBVIE INC.
$67,295
Allergan, Inc.
$52,986
Takeda Pharmaceuticals U.S.A., Inc.
$37,716
ARGENX US, INC.
$4,604
Teva Pharmaceuticals USA, Inc.
$1,357
EMD Serono, Inc.
$1,129
Novartis Pharmaceuticals Corporation
$1,104
Biogen, Inc.
$927
GENZYME CORPORATION
$811
Amgen Inc.
$800
UCB, Inc.
$719
Eisai Inc.
$714
Neurocrine Biosciences, Inc.
$642
PFIZER INC.
$558
SK Life Science, Inc.
$553
Genentech USA, Inc.
$540
Lundbeck LLC
$494
MDD US Operations, LLC
$487
Neurelis, Inc.
$391
Supernus Pharmaceuticals, Inc.
$384
Allergan Inc.
$380
Adamas Pharmaceuticals, Inc.
$346
IMPEL PHARMACEUTICALS INC.
$327
Amneal Pharmaceuticals LLC
$314
Upsher-Smith Laboratories LLC
$281
Lilly USA, LLC
$272
Otsuka America Pharmaceutical, Inc.
$269
Alexion Pharmaceuticals, Inc.
$245
Biohaven Pharmaceutical Holding Company Ltd.
$241
Kyowa Kirin, Inc.
$234
BANNER LIFE SCIENCES, LLC
$222
Avanir Pharmaceuticals, Inc.
$190
Merz Pharmaceuticals, LLC
$165
Mallinckrodt Hospital Products Inc.
$165
EISAI INC.
$153
Acorda Therapeutics, Inc
$133
Grifols USA, LLC
$124
UPSHER-SMITH LABORATORIES LLC
$119
Bayer HealthCare Pharmaceuticals Inc.
$102
ACADIA Pharmaceuticals Inc
$93
US WorldMeds, LLC
$92
SCILEX PHARMACEUTICALS INC.
$92
AstraZeneca Pharmaceuticals LP
$90
LivaNova USA, Inc.
$89
Avion Pharmaceuticals
$89
Janssen Pharmaceuticals, Inc
$79
Scilex Pharmaceuticals Inc.
$76
Impax Laboratories, Inc.
$73
Biohaven Pharmaceuticals, Inc.
$67
GE HEALTHCARE
$62
Mallinckrodt LLC
$48
Egalet US Inc
$43
ASSERTIO THERAPEUTICS, Inc.
$41
MITSUBISHI TANABE PHARMA AMERICA, INC.
$39
E.R. Squibb & Sons, L.L.C.
$34
Stryker Corporation
$34
Celgene Corporation
$32
Boston Scientific Corporation
$32
Amylyx Pharmaceuticals, Inc.
$32
SANOFI-AVENTIS U.S. LLC
$27
CATALYST PHARMACEUTICALS, INC.
$26
Catalyst Pharmaceuticals, Inc.
$24
Vanda Pharmaceuticals Inc.
$23
TG THERAPEUTICS, INC.
$22
Mallinckrodt Enterprises LLC
$22
Bausch Health US, LLC
$22
BOSTON SCIENTIFIC CORPORATION
$20
TG Therapeutics, Inc.
$19
Kedrion Biopharma, Inc.
$19
Merz North America, Inc.
$17
Averitas Pharma Inc.
$17
Alnylam Pharmaceuticals Inc.
$14
Currax Pharmaceuticals LLC
$14
Top 3 companies account for 76.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · ARYMO ER · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Albuked · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COMIRNATY · CONTRAVE · COPAXONE · DUOPA · Dhivy · EMGALITY · FYCOMPA · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Gralise · HYQVIA · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LINZESS · LUMIZYME · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NEXVIAZYME · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PLEGRIDY · POMPE - DISEASE · PONVORY · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RADICAVA · RELYVRIO · REXULTI · REYVOW · RYTARY · Rebif · Rystiggo · SOLIRIS · SPECTRA WAVEWRITER · SPRAVATO · SPRIX · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREVO · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VIIBRYD · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WaveWriter Alpha Prime 16 · XADAGO · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace SymTouch Sumatriptan Injection · Zilbrysq · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in GA.
Geographic Context
Neurologists within 10 mi
83
Per 100K population
40.3
County median income
$53,197
Nearest hospital
DOCTORS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shaefer is a mixed practice specialist, with above-average Medicare volume (top 5% in GA), with speaking/promotional industry engagement in the top 3% of GA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shaefer experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Shaefer performed 16,000 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shaefer receive payments from pharmaceutical companies?
Yes. Dr. Shaefer received a total of $249,455 from 74 companies across 1,439 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shaefer's costs compare to other neurologists in Augusta?
Dr. Shaefer's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shaefer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Augusta
Browse neurologists in Augusta ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology